Immunization in inflammatory bowel diseases: recommendations on vaccines administration

Symmers WS. Opportunistic Infections. The Concept of Óp-portunistic Infections. Proc R Soc Med 1965; 58(5): 341‒6.

Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, et al. Association of NOD2 leucocine-rich repeat variants with susceptibility to Crohn´s disease. Nature 2001; 411(6837): 599‒603.

Baldassano RN, Bradfield JP, Monos DS, Kim CE, Glessner JT, Casalunovo T,et al. Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's dis-ease. Clin Gastroenterol Hepatol 2007; 5(8): 972‒6.

Lu Y, Jacobson D, Bousvaros A. Immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis 2009; 15(9): 1417‒23.

Rahier JF, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infec-tions in inflammatory bowel disease. J Crohns Colitis 2014; 8(6): 443‒68.

Aberra FN, Lichtenstein GR. Methods to avoid infections in patients with inflammatory bowel disease. Inflamm Bowel Dis 2005; 11(7): 685‒95.

Viget N, Vernier-Massouille G, Salmon-Ceron D, Yazdanpanah Y, Colombel JF. Opportunistic infections in patients with inflam-matory bowel disease: prevention and diagnosis. Gut 2008; 57(4): 549‒58.

Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national sur-vey of the prevalence and impact of Clostridium difficile in-fection among hospitalized inflammatory bowel disease pa-tients. Am J Gastroenterol 2008; 103(6): 1443‒50.

Melmed GY. Vaccination strategies for patients with inflam-matory bowel disease on immunomodulators and biologics. In-flamm Bowel Dis 2009; 15(9): 1410‒6.

Reich J, Wasan S, Farraye FA. Vaccinating Patients With In-flammatory Bowel Disease. Gastroenterol Hepatol (N Y) 2016; 12(9): 540‒6.

Gisbert JP, Chaparro M. Vaccination strategies in patients with IBD. Nat Rev Gastroenterol Hepatol 2013; 10(5): 277‒85.

Melmed GY, Ippoliti AF, Papadakis KA, Tran TT, Birt JL, Lee SK, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol 2006; 101(8): 1834‒40.

Deutsch DE, Olson AD, Kraker S, Dickinson CJ. Overwhelming varicella pneumonia in a patient with Crohn's disease treated with 6-mercaptopurine. J Pediatr Gastroenterol Nutr 1995; 20(3): 351‒3.

Korelitz BI, Fuller SR, Warman JI, Goldberg MD. Shingles dur-ing the course of treatment with 6-mercaptopurine for in-flammatory bowel disease. Am J Gastroenterol 1999; 94(2): 424‒6.

Elkayam O, Ablin J, Caspi D. Safety and efficacy of vaccina-tion against streptococcus pneumonia in patients with rheu-matic diseases. Autoimmun Rev 2007; 6(5): 312‒4.

Jarrett MP, Schiffman G, Barland P, Grayzel AI. Impaired re-sponse to pneumococcal vaccine in systemic lupus erythema-tosus. Arthritis Rheum 1980; 23(11): 1287‒93.

Nies K, Boyer R, Stevens R, Louie J. Anti-tetanus toxoid anti-body synthesis after booster immunization in systemic lupus erythematosus. Comparison of the in vitro and in vivo re-sponses. Arthritis Rheum 1980; 23(12): 1343‒50.

Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol 2002; 29(12): 2555‒7.

Recommendations of the Advisory Committee on Immuniza-tion Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. MMWR Recomm Rep 1993; 42(RR‒4): 1‒18.

Dezfoli S, Melmed GY. Vaccination issues in patients with in-flammatory bowel disease receiving immunosuppression. Gas-troenterol Hepatol (N Y) 2012; 8(8): 504‒12.

Dotan I, Werner L, Vigodman S, Agarwal S, Pfeffer J, Horowitz N, et al. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflamm Bowel Dis 2012; 18(2): 261‒8.

Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gas-troenterol 2008; 103(3): 631‒6.

Tamas E, Mannor S, Shevchuk M. Cervical squamous lesions as-sociated with ulcerative colitis. Mod Pathol 2002; 15: 212A.

Bhatia J, Bratcher J, Korelitz B, Vakher K, Mannor S, Shevchuk M, et al. Abnormalities of uterine cervix in women with inflam-matory bowel disease. World J Gastroenterol. 2006; 12(38): 6167‒71.

Chevaux JB, Nani A, Oussalah A, Venard V, Bensenane M, Belle A, et al. Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France. Inflamm Bowel Dis 2010; 16(6): 916‒24.

Sempere L, Almenta I, Barrenengoa J, Gutiérrez A, Villanueva CO, de-Madaria E, et al. Factors predicting response to hepati-tis B vaccination in patients with inflammatory bowel disease. Vaccine 2013; 31(30): 3065‒71.

Cheent K, Nolan J, Shariq S, Kiho L, Pal A, Arnold J. Case Re-port: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's disease. J Crohns Colitis 2010; 4(5): 603‒5.

Villumsen M, Jess T, Sørup S, Ravn H, Sturegård E, Benn CS, et al. Risk of inflammatory bowel disease following Bacille Calmette-Guérin and smallpox vaccination: a population-based Danish case-cohort study. Inflamm Bowel Dis 2013; 19(8): 1717‒24.

Leigh RJ, Turnberg LA. BCG vaccination and Crohn's disease. Dig Dis Sci 1980; 25(12): 972.

Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn's disease. An international coop-erative study. Scand J Gastroenterol 1987; 22(8): 1009‒24.

Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 2005; 54(3): 357‒63.